Translator Disclaimer
1 September 2016 ISONIAZID AND RIFAMPIN PHARMACOKINETICS IN TWO ASIAN ELEPHANTS (ELEPHAS MAXIMUS) INFECTED WITH MYCOBACTERIUM TUBERCULOSIS
Author Affiliations +
Abstract

This report describes the pharmacokinetic profiles of chronically administered oral isoniazid and rifampin in one adult male and one adult female Asian elephant (Elephas maximus) that were asymptomatically infected with Mycobacterium tuberculosis. Rifampin's half-life was reduced when compared to previous single-dose pharmacokinetic profiles of healthy uninfected Asian elephants. Both elephants experienced delayed absorption of isoniazid and rifampin as compared to previous pharmacokinetic studies in this species. The altered pharmacokinetics of both drugs in repeated-dosing clinical situations underscores the need for individual therapeutic drug monitoring for tuberculosis treatment.

Copyright 2016 by American Association of Zoo Veterinarians
Eric F. Egelund, Ramiro Isaza, Abdullah Alsultan, and Charles A. Peloquin "ISONIAZID AND RIFAMPIN PHARMACOKINETICS IN TWO ASIAN ELEPHANTS (ELEPHAS MAXIMUS) INFECTED WITH MYCOBACTERIUM TUBERCULOSIS," Journal of Zoo and Wildlife Medicine 47(3), 868-871, (1 September 2016). https://doi.org/10.1638/2015-0174.1
Received: 3 August 2015; Published: 1 September 2016
JOURNAL ARTICLE
4 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top